MMR News and Research

RSS

Resurgence of mumps orchitis among teenage boys and young men

Urologists at a leading Irish hospital have reported an alarming increase in the number of teenage boys and young men developing mumps orchitis, in a paper published in the April issue of the urology journal BJUI.

30 Mar 2010

Columbia University, FairChoice Systems sign agreement to market student health information system

Columbia University and FairChoice Systems, Inc. have signed a multi-year commercialization agreement that will bring to market a cost-effective, online student health information system developed and implemented by Columbia University's own Student Health Services.

2 Mar 2010

Novartis' Tasigna capsules granted priority review by FDA for treatment of adult patients with Ph+ CML

Novartis announced today that Tasigna® (nilotinib) 200 mg capsules has been granted priority review by the US Food and Drug Administration for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase.

19 Feb 2010

Measles vaccine does not increase risk of autism in children, reveals Polish study

As a pivotal paper linking childhood vaccinations to autism is discredited, a new study finds no evidence that the measles vaccine—given alone or as part of a combined measles, mumps, and rubella (MMR) vaccine—increases the risk of autism in children. The study appears in The Pediatric Infectious Disease Journal (www.pidj.com), published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

10 Feb 2010

Expert available to discuss Lancet’s retraction of paper on autism study

Rae Sonnenmeier, clinical associate professor of communication sciences and disorders at the University of New Hampshire and staff member at UNH's Institute on Disability, is available to discuss the announcement yesterday (Feb. 2, 2010) by the medical journal The Lancet regarding the retraction of a paper that caused a 12-year international battle over the links between the three-in-one childhood vaccine MMR (measles, mumps, rubella) and autism.

4 Feb 2010

Research retraction underscores the safety and efficacy of MMR vaccines

The Lancet, a premier British medical journal, today retracted a study published in 1998 that drew a link between the measles, mumps and rubella (MMR) vaccine and increased incidence of autism.

3 Feb 2010

Study linking autism and vaccines is retracted by medical journal

The Lancet has formally retracted a controversial paper published 12 years ago that purported the measles-mumps-rubella vaccine causes autism.

3 Feb 2010

MMR Information Systems announces the opening of MMR University

MMR Information Systems, Inc., which provides MMRPro, a professional, integrated end-to-end document management system for the healthcare vertical (www.mymedicalrecordsmd.com), as well as consumer-controlled Personal Health Records (PHRs) (www.mymedicalrecords.com) and electronic safe deposit box storage solutions (www.myesafedepositbox.com), has announced the opening of MMR University to educate resellers, distributors, doctors, hospitals, and other potential customers about MMRPro.

27 Jan 2010

Bioheart signs distribution agreements to market Home Heart Failure Monitoring Systems in U.S.

Bioheart, Inc. announced today that the company has signed distribution agreements with Restoration Medical, McRay Medical, Alamo Scientific and Morey Medical. These distributors will assist Bioheart with introducing its Home Heart Failure Monitoring Systems to physicians and hospitals throughout the United States.

6 Jan 2010

Tasigna demonstrates greater efficacy over Gleevec in chronic Ph+ CML patients

In a large Phase III clinical trial, Tasigna (nilotinib capsules) demonstrated greater efficacy over Gleevec (imatinib) in the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. The new clinical data were just presented as a late breaking abstract at the 51st annual meeting of the American Society of Hematology (ASH), in New Orleans, Louisiana.

11 Dec 2009

MMR Information Systems to add new feature in its personal health record website

MMR Information Systems, Inc. announced today it will add a clinical trials information service to its MyMedicalRecords Personal Health Record site, www.mymedicalrecords.com.

23 Nov 2009

MMR Information Systems and Unis-Tonghe Technology enter into a definitive agreement

MMR Information Systems, Inc., and Unis-Tonghe Technology (Zhengzhou) Co., Ltd, announced that they will enter into a definitive agreement by the end of this year to form a joint venture to build a customized version of MMR's proprietary personal health record ("PHR") services (www.mymedicalrecords.com) and professional document imaging and management solutions in China.

19 Nov 2009

The Center for Modeling Optimal Outcomes discovers causal path of autism

During its research into the application of neuroscience in business, a New Jersey based think tank, The Center for Modeling Optimal Outcomes®, LLC (The Center) made an inadvertent and amazing discovery.

18 Nov 2009

MinuteClinic praises practitioners for providing affordable medical treatment and quality patient-centered care

In celebration of National Nurse Practitioner Week (Nov. 8-14), MinuteClinic, the pioneer and largest provider of retail health care centers in the United States, salutes practitioners across the country who deliver patient-centered care and help to increase access to high-quality, affordable medical treatment.

12 Nov 2009

Sanofi Pasteur presents Menactra vaccine safety data at the IDSA

Sanofi Pasteur, the vaccines division of sanofi-aventis Group, presented Safety of a Quadrivalent (A,C,Y,W-135) Meningococcal Vaccine When Given to Infants with Other Pediatric Vaccines at the 47th Annual Meeting of the Infectious Diseases Society of America (IDSA) this past weekend.

2 Nov 2009

MMR Information Systems offers free guide to Personal Health Records

MMR Information Systems, Inc. announced today that it is offering a free guide to Personal Health Records ("PHRs") by Dr. Arnold W. Klein, a world-renowned Beverly Hills Dermatologist, through its MyMedicalRecords PHR website www.mymedicalrecords.com. The Company made the announcement in response to the White House declaring the H1N1 "Swine Flu" virus a National Emergency.

31 Oct 2009

MMR Information Systems' MMRPro enables digitizing patient records without major makeovers

MMR Information Systems' MMRPro, which enables doctors who do not have an Electronic Medical Records (EMR) system to digitize and store paper records through a secure Web-based portal, is envisioned as the bridge between fully paper-based medical offices and the adoption of computerized medical records to qualify for stimulus funds under the American Recovery and Reinvestment Act (ARRA).

28 Oct 2009

Vaccination rates need improvement; racial and ethnic disparities in vaccination coverage

More teenagers are being vaccinated against human papillomavirus (HPV), meningococcal meningitis and pertussis (whooping cough), though the rates are still too low, according to recently released government data and a panel of experts convened by the National Foundation for Infectious Diseases (NFID).

27 Oct 2009

Novartis' Tasigna capsules meets primary endpoint in comparison trial with Gleevec

Novartis announced today that Tasigna (nilotinib) 200 mg capsules met its primary endpoint in the first head-to-head comparison with the company's groundbreaking drug Gleevec (imatinib mesylate) tablets*. Tasigna produced faster and deeper responses than Gleevec when given as first-line therapy for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna was well tolerated in the study.

20 Oct 2009

MMR Information Systems, Unis-Tonghe Technology ink Memorandum of Understanding

MMR Information Systems, Inc. and Unis-Tonghe Technology (Zhengzhou) Co., Ltd., announced today that the companies have entered into a Memorandum of Understanding ("MOU") and plan to sign a Master Agreement by December 15, 2009.

15 Oct 2009